Preclinical models are relatively underutilized and underfunded resources for modeling the pathogenesis and prevention of ovarian cancers. Several reviews have detailed the numerous published models of ovarian cancer. In this review, we will provide an overview of experimental model systems, their strengths and limitations, and use selected models to illustrate how they can be used to address specific issues about ovarian cancer pathogenesis. We will then highlight some of the preclinical prevention studies performed to date and discuss experiments needed to address important unanswered questions about ovarian cancer prevention strategies
The National Academies of Sciences, Engineering, and Medicine convened an expert committee to examin...
Epithelial ovarian cancer (OvCa) is associated with high mortality and, as the majority (>75%) of wo...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
Ovarian cancer is the most lethal of all of the gynecological cancers and can arise from any cell ty...
Development of mouse models representing human spontaneous ovarian cancer has been hampered by the l...
Introduction: Ovarian cancer is caused by malignant changes in the cells of the ovary. In various st...
A large variety of mouse models for cancer exist, also in the field of ovarian cancer. Each model po...
High-grade serous ovarian cancer remains the most common sub-type of ovarian cancer and, characteriz...
Ovarian cancer is usually diagnosed at an advanced stage, rendering the possibility of cure unlikely...
Immunotherapy has emerged as one of the most promising approaches for ovarian cancer treatment. The ...
The goal of ovarian cancer screening is to detect disease when confined to the ovary (stage I) and t...
Abstract Cancer is a major stress for public well‐being and is the most dreadful disease. The models...
This Zenodo record is a permanently preserved version of a PREreview. You can view the complete PREr...
Ovarian cancer (OC) is the leading cause of death from a gynecological malignancy in the United Stat...
Ovarian cancer (OC) is one of the leading causes of female cancer death. Recent studies have documen...
The National Academies of Sciences, Engineering, and Medicine convened an expert committee to examin...
Epithelial ovarian cancer (OvCa) is associated with high mortality and, as the majority (>75%) of wo...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
Ovarian cancer is the most lethal of all of the gynecological cancers and can arise from any cell ty...
Development of mouse models representing human spontaneous ovarian cancer has been hampered by the l...
Introduction: Ovarian cancer is caused by malignant changes in the cells of the ovary. In various st...
A large variety of mouse models for cancer exist, also in the field of ovarian cancer. Each model po...
High-grade serous ovarian cancer remains the most common sub-type of ovarian cancer and, characteriz...
Ovarian cancer is usually diagnosed at an advanced stage, rendering the possibility of cure unlikely...
Immunotherapy has emerged as one of the most promising approaches for ovarian cancer treatment. The ...
The goal of ovarian cancer screening is to detect disease when confined to the ovary (stage I) and t...
Abstract Cancer is a major stress for public well‐being and is the most dreadful disease. The models...
This Zenodo record is a permanently preserved version of a PREreview. You can view the complete PREr...
Ovarian cancer (OC) is the leading cause of death from a gynecological malignancy in the United Stat...
Ovarian cancer (OC) is one of the leading causes of female cancer death. Recent studies have documen...
The National Academies of Sciences, Engineering, and Medicine convened an expert committee to examin...
Epithelial ovarian cancer (OvCa) is associated with high mortality and, as the majority (>75%) of wo...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...